Agilon Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the Annual Meeting of Stockholders held by Agilon Health, Inc. on June 2, 2026. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following proposals were submitted to a vote of security holders:
- Proposal 1: Election of Directors
- Diana McKenzie: Elected (11,679,958 For; 177,760 Against).
- Karen McLoughlin: Elected (9,525,491 For; 2,332,208 Against).
- Ronald Williams: Elected (10,837,623 For; 1,019,347 Against).
- All three directors were elected as Class II directors to serve until the 2029 annual meeting.
- Proposal 2: Ratification of Independent Auditor
- Stockholders ratified the appointment of Ernst & Young LLP for the fiscal year ending December 31, 2026.
- Votes: 13,712,368 For; 6,616 Against.
- Proposal 3: Executive Compensation (Say-on-Pay)
- Stockholders approved the advisory vote on executive compensation.
- Votes: 11,228,258 For; 627,870 Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to calculate the percentage of votes cast for each proposal.
- Note the significant number of "Against" votes for Director Karen McLoughlin (2,332,208) compared to the other nominees.
- Confirm the term end date for the newly elected Class II directors (2029).
- Verify the appointment of Ernst & Young LLP as the independent auditor for the 2026 fiscal year.